These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 37482023)
1. Novel fused imidazotriazines acting as promising top. II inhibitors and apoptotic inducers with greater selectivity against head and neck tumors: Design, synthesis, and biological assessments. Al-Karmalawy AA; Rashed M; Sharaky M; Abulkhair HS; Hammouda MM; Tawfik HO; Shaldam MA Eur J Med Chem; 2023 Nov; 259():115661. PubMed ID: 37482023 [TBL] [Abstract][Full Text] [Related]
2. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives. Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494 [TBL] [Abstract][Full Text] [Related]
3. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130 [TBL] [Abstract][Full Text] [Related]
4. Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction. Gaber AA; Abo Elmaaty A; Sharaky M; Mosa AA; Yahya Abdullah Alzahrani A; Shaaban S; Eldehna WM; Al-Karmalawy AA Bioorg Chem; 2024 Apr; 145():107223. PubMed ID: 38387399 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors. El-Adl K; El-Helby AA; Sakr H; Elwan A Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414 [TBL] [Abstract][Full Text] [Related]
6. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related]
7. New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents. Sobh EA; Kassab AE; El-Khouly EA; S A Hassan M Bioorg Chem; 2024 Mar; 144():107158. PubMed ID: 38301427 [TBL] [Abstract][Full Text] [Related]
8. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953 [TBL] [Abstract][Full Text] [Related]
9. Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors. Sakr H; Ayyad RR; El-Helby AA; Khalifa MM; Mahdy HA Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000456. PubMed ID: 33554352 [TBL] [Abstract][Full Text] [Related]